Stockreport

Aviragen to merge with Vaxart [Seeking Alpha]

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF Aviragen to merge with VaxartAviragen Therapeutics (NASDAQ:AVIR) inks amerger agreement with privately heldVaxart, a developer of oral recombinant vaccines. The combined [Read more]